1. Academic Validation
  2. A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1

A small-molecule VHL molecular glue degrader for cysteine dioxygenase 1

  • Nat Chem Biol. 2025 Nov;21(11):1688-1696. doi: 10.1038/s41589-025-01936-x.
Antonin Tutter 1 Dennis Buckley 1 Andrei A Golosov 2 Xiaolei Ma 3 Wei Shu 3 Daniel J J McKay 2 Veronique Darsigny 1 Dustin Dovala 4 Rohan Beckwith 1 Jonathan Solomon 1 Pasupuleti Rao 1 Lei Xu 1 Aleem Fazal 1 Andreas Lingel 5 Charles Wartchow 4 Jennifer S Cobb 1 Amanda Hachey 1 Jennifer Tullai 1 Gregory A Michaud 6
Affiliations

Affiliations

  • 1 Discovery Sciences, Novartis Biomedical Research, Cambridge, MA, USA.
  • 2 Global Discovery Chemistry, Novartis Biomedical Research, Cambridge, MA, USA.
  • 3 Global Discovery Chemistry, Novartis Biomedical Research, Emeryville, CA, USA.
  • 4 Discovery Sciences, Novartis Biomedical Research, Emeryville, CA, USA.
  • 5 Global Discovery Chemistry, Novartis Biomedical Research, Basel, Switzerland.
  • 6 Discovery Sciences, Novartis Biomedical Research, Cambridge, MA, USA. [email protected].
Abstract

The von Hippel-Lindau tumor suppressor gene product (pVHL) is an E3 Ligase substrate receptor that binds proline-hydroxylated hypoxia-inducible factor HIF1α, leading to its ubiquitin-dependent degradation. By using protein arrays, we identified a small molecule that binds the HIF1α-binding pocket on pVHL and functions as a molecular glue degrader of the neosubstrate cysteine dioxygenase (CDO1) by recruiting it into the VHL-Cullin-RING E3 Ligase complex and leading to its selective degradation. The CDO1-binding region involved in VHL recruitment was characterized through a combination of mutagenesis and protein-protein docking coupled with molecular-dynamics-based solvation analysis. The X-ray structure of the ternary complexes of VHL, CDO1 and degrader molecules confirms the binding region prediction and provides atomic insights into key molecular glue interactions.

Figures
Products